Related Experiment Video
Updated: May 30, 2026
05:06
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
A delayed fatal metastatic Hürthle cell carcinoma
S Oaleed Noordally1, Schoeb Sohawon, Ruth Duttmann
1Department of Otolaryngology and Cervico-Facial Surgery, CHU Brugmann, Free University of Brussels, Brussels, Belgium. Sheikoaleed.Noordally@chu-brugmann.be
Acta Medica (Hradec Kralove)
|August 17, 2011
Summary
This case report details an aggressive Hürthle cell carcinoma (a thyroid cancer variant) in a young adult, presenting with widespread metastases and resistance to standard treatments.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Hürthle cell carcinoma (HCC) is a rare variant of follicular thyroid carcinoma.
- While known, HCC in young patients is exceptionally uncommon.
Observation:
- A 26-year-old Turkish male presented with advanced, metastatic HCC.
- The cancer involved the trachea, lungs, mediastinum, and bilateral cervical/mediastinal lymph nodes.
Findings:
- The patient's diagnosis revealed an aggressive, metastatic Hürthle cell carcinoma.
- The cancer demonstrated resistance to surgery, chemotherapy, and radioactive iodine therapy.
Implications:
- This case highlights the potential for aggressive Hürthle cell carcinoma in young adults.
- It underscores the challenges in treating advanced, treatment-resistant thyroid cancer.
- Further research into novel therapeutic strategies for aggressive HCC is warranted.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...